{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:18:42Z","timestamp":1787728722055,"version":"build-2784847793"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2023YFC2506000"],"award-info":[{"award-number":["2023YFC2506000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2024QH412"],"award-info":[{"award-number":["ZR2024QH412"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Project of Jinan Microecological Biomedicine Shandong Laboratory","award":["JNL-2023010Q"],"award-info":[{"award-number":["JNL-2023010Q"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics &amp; Antimicro. Prot."],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s12602-026-11011-z","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T10:47:02Z","timestamp":1774954022000},"page":"7965-7983","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pediococcus pentosaceus JNL0053 Mitigates DSS-induced Colitis in Mice Via the IL-22\u2013Gut Barrier Pathway"],"prefix":"10.1007","volume":"18","author":[{"given":"Shujun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changzhong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianbo","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"11011_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102337","volume":"66","author":"H Yang","year":"2023","unstructured":"Yang H et al (2023) Comparative effectiveness of ustekinumab vs. vedolizumab for anti-TNF-na\u00efve or anti-TNF-exposed Crohn\u2019s disease: a multicenter cohort study. EClinicalMedicine 66:102337","journal-title":"EClinicalMedicine"},{"key":"11011_CR2","first-page":"247","volume":"8","author":"KA Head","year":"2003","unstructured":"Head KA, Jurenka JS (2003) Inflammatory bowel disease part 1: ulcerative colitis\u2013pathophysiology and conventional and alternative treatment options. Altern Med review: J Clin therapeutic 8:247\u2013283","journal-title":"Altern Med review: J Clin therapeutic"},{"key":"11011_CR3","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMra1102942","volume":"365","author":"S Danese","year":"2011","unstructured":"Danese S, Fiocchi C (2011) Ulcerative colitis. N Engl J Med 365:1713\u20131725","journal-title":"N Engl J Med"},{"key":"11011_CR4","doi-asserted-by":"publisher","first-page":"874","DOI":"10.14309\/ajg.0000000000000183","volume":"114","author":"R Ungaro","year":"2019","unstructured":"Ungaro R, Colombel JF, Lissoos T, Peyrin-Biroulet L (2019) A treat-to-target update in ulcerative colitis: a systematic review. Am J Gastroenterol 114:874\u2013883","journal-title":"Am J Gastroenterol"},{"key":"11011_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.25122\/jml-2018-0075","volume":"12","author":"SS Seyedian","year":"2019","unstructured":"Seyedian SS, Nokhostin F, Malamir MD (2019) A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease. J Med Life 12:113\u2013122","journal-title":"J Med Life"},{"key":"11011_CR6","doi-asserted-by":"publisher","first-page":"R79","DOI":"10.1186\/gb-2012-13-9-r79","volume":"13","author":"XC Morgan","year":"2012","unstructured":"Morgan XC et al (2012) Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol 13:R79","journal-title":"Genome Biol"},{"key":"11011_CR7","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.chom.2014.02.005","volume":"15","author":"D Gevers","year":"2014","unstructured":"Gevers D et al (2014) The treatment-naive microbiome in new-onset Crohn\u2019s disease. Cell host & microbe 15:382\u2013392","journal-title":"Cell host & microbe"},{"key":"11011_CR8","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1053\/j.gastro.2014.02.009","volume":"146","author":"AD Kostic","year":"2014","unstructured":"Kostic AD, Xavier RJ, Gevers D (2014) The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology 146:1489\u20131499","journal-title":"Gastroenterology"},{"key":"11011_CR9","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.trsl.2006.11.009","volume":"149","author":"MG Neuman","year":"2007","unstructured":"Neuman MG (2007) Immune dysfunction in inflammatory bowel disease. Transl Res 149:173\u2013186","journal-title":"Transl Res"},{"key":"11011_CR10","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","volume":"569","author":"J Lloyd-Price","year":"2019","unstructured":"Lloyd-Price J et al (2019) Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature 569:655\u2013662","journal-title":"Nature"},{"key":"11011_CR11","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41579-019-0213-6","volume":"17","author":"M Schirmer","year":"2019","unstructured":"Schirmer M, Garner A, Vlamakis H, Xavier RJ (2019) Microbial genes and pathways in inflammatory bowel disease. Nat Rev Microbiol 17:497\u2013511","journal-title":"Nat Rev Microbiol"},{"key":"11011_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrgastro.2016.169","volume":"14","author":"MA Odenwald","year":"2017","unstructured":"Odenwald MA, Turner JR (2017) The intestinal epithelial barrier: a therapeutic target? Nat Rev Gastroenterol Hepatol 14:9\u201321","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"11011_CR13","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nature06005","volume":"448","author":"RJ Xavier","year":"2007","unstructured":"Xavier RJ, Podolsky DK (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448:427\u2013434","journal-title":"Nature"},{"key":"11011_CR14","doi-asserted-by":"publisher","first-page":"eabp8798","DOI":"10.1126\/sciadv.abp8798","volume":"8","author":"J Liu","year":"2022","unstructured":"Liu J et al (2022) Mucoadhesive probiotic backpacks with ROS nanoscavengers enhance the bacteriotherapy for inflammatory bowel diseases. Sci Adv 8:eabp8798","journal-title":"Sci Adv"},{"key":"11011_CR15","doi-asserted-by":"publisher","first-page":"e2102580","DOI":"10.1002\/adma.202102580","volume":"33","author":"Z Li","year":"2021","unstructured":"Li Z et al (2021) Chemically and Biologically Engineered Bacteria-Based Delivery Systems for Emerging Diagnosis and Advanced Therapy. Adv Mater (Deerfield Beach Fla) 33:e2102580","journal-title":"Adv Mater (Deerfield Beach Fla)"},{"key":"11011_CR16","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1111\/1751-7915.13583","volume":"13","author":"X Bian","year":"2020","unstructured":"Bian X et al (2020) Pediococcus pentosaceus LI05 alleviates DSS-induced colitis by modulating immunological profiles, the gut microbiota and short-chain fatty acid levels in a mouse model. Microb Biotechnol 13:1228\u20131244","journal-title":"Microb Biotechnol"},{"key":"11011_CR17","doi-asserted-by":"publisher","first-page":"6927","DOI":"10.1038\/s41598-017-07091-1","volume":"7","author":"D Shi","year":"2017","unstructured":"Shi D et al (2017) Administration of Lactobacillus salivarius LI01 or Pediococcus pentosaceus LI05 prevents CCl(4)-induced liver cirrhosis by protecting the intestinal barrier in rats. Sci Rep 7:6927","journal-title":"Sci Rep"},{"key":"11011_CR18","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1016\/j.cmet.2024.06.010","volume":"36","author":"L Bonetti","year":"2024","unstructured":"Bonetti L et al (2024) A Th17 cell-intrinsic glutathione\/mitochondrial-IL-22 axis protects against intestinal inflammation. Cell Metab 36:1726\u20131744e.e1710","journal-title":"Cell Metab"},{"key":"11011_CR19","doi-asserted-by":"publisher","first-page":"6734","DOI":"10.1038\/ncomms7734","volume":"6","author":"L Macia","year":"2015","unstructured":"Macia L et al (2015) Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nat Commun 6:6734","journal-title":"Nat Commun"},{"key":"11011_CR20","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature12331","volume":"500","author":"K Atarashi","year":"2013","unstructured":"Atarashi K et al (2013) Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500:232\u2013236","journal-title":"Nature"},{"key":"11011_CR21","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.chom.2016.07.001","volume":"20","author":"M Kim","year":"2016","unstructured":"Kim M, Qie Y, Park J, Kim CH (2016) Gut microbial metabolites fuel host antibody responses. Cell Host Microbe 20:202\u2013214","journal-title":"Cell Host Microbe"},{"key":"11011_CR22","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.immuni.2019.02.014","volume":"50","author":"Z Al Nabhani","year":"2019","unstructured":"Al Nabhani Z et al (2019) A weaning reaction to microbiota is required for resistance to immunopathologies in the adult. Immunity 50:1276\u20131288e.e1275","journal-title":"Immunity"},{"key":"11011_CR23","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature12721","volume":"504","author":"Y Furusawa","year":"2013","unstructured":"Furusawa Y et al (2013) Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504:446\u2013450","journal-title":"Nature"},{"key":"11011_CR24","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1126\/science.1241165","volume":"341","author":"PM Smith","year":"2013","unstructured":"Smith PM et al (2013) The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341:569\u2013573","journal-title":"Science"},{"key":"11011_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrgastro.2013.151","volume":"11","author":"FG Schaap","year":"2014","unstructured":"Schaap FG, Trauner M, Jansen PL (2014) Bile acid receptors as targets for drug development. Nat Rev Gastroenterol Hepatol 11:55\u201367","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"11011_CR26","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.cmet.2011.03.019","volume":"13","author":"MJ Potthoff","year":"2011","unstructured":"Potthoff MJ et al (2011) FGF15\/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1\u03b1 pathway. Cell Metab 13:729\u2013738","journal-title":"Cell Metab"},{"key":"11011_CR27","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-019-0258-z","volume":"17","author":"A Lavelle","year":"2020","unstructured":"Lavelle A, Sokol H (2020) Gut microbiota-derived metabolites as key actors in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 17:223\u2013237","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"11011_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.chom.2017.06.007","volume":"22","author":"M Wlodarska","year":"2017","unstructured":"Wlodarska M et al (2017) Indoleacrylic acid produced by commensal Peptostreptococcus species suppresses inflammation. Cell Host Microbe 22:25\u201337.e26","journal-title":"Cell Host Microbe"},{"key":"11011_CR29","doi-asserted-by":"publisher","first-page":"122530","DOI":"10.1016\/j.biomaterials.2024.122530","volume":"307","author":"B Li","year":"2024","unstructured":"Li B et al (2024) Magnetic natural lipid nanoparticles for oral treatment of colorectal cancer through potentiated antitumor immunity and microbiota metabolite regulation. Biomaterials 307:122530","journal-title":"Biomaterials"},{"key":"11011_CR30","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s41575-022-00631-9","volume":"19","author":"PD Cani","year":"2022","unstructured":"Cani PD, Depommier C, Derrien M, Everard A, de Vos WM (2022) Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms. Nat Rev Gastroenterol Hepatol 19:625\u2013637","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"11011_CR31","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1038\/s41467-023-39403-7","volume":"14","author":"JB Lynch","year":"2023","unstructured":"Lynch JB et al (2023) Gut microbiota Turicibacter strains differentially modify bile acids and host lipids. Nat Commun 14:3669","journal-title":"Nat Commun"},{"key":"11011_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.micpath.2016.05.015","volume":"106","author":"G Dubourg","year":"2017","unstructured":"Dubourg G, Surenaud M, L\u00e9vy Y, H\u00fce S, Raoult D (2017) Microbiome of HIV-infected people. Microb Pathog 106:85\u201393","journal-title":"Microb Pathog"},{"key":"11011_CR33","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41420-023-01524-9","volume":"9","author":"C Zhou","year":"2023","unstructured":"Zhou C, Gao Y, Ding P, Wu T, Ji G (2023) The role of CXCL family members in different diseases. Cell death discovery 9:212","journal-title":"Cell death discovery"},{"key":"11011_CR34","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41568-023-00635-w","volume":"24","author":"TR Mempel","year":"2024","unstructured":"Mempel TR, Lill JK, Altenburger LM (2024) How chemokines organize the tumour microenvironment. Nat Rev Cancer 24:28\u201350","journal-title":"Nat Rev Cancer"},{"key":"11011_CR35","doi-asserted-by":"publisher","first-page":"e20192195","DOI":"10.1084\/jem.20192195","volume":"217","author":"M Keir","year":"2020","unstructured":"Keir M, Yi Y, Lu T, Ghilardi N (2020) The role of IL-22 in intestinal health and disease. J Exp Med 217:e20192195","journal-title":"J Exp Med"},{"key":"11011_CR36","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1080\/21645515.2018.1461300","volume":"14","author":"A Markota","year":"2018","unstructured":"Markota A, Endres S, Kobold S (2018) Targeting interleukin-22 for cancer therapy. Hum Vaccin Immunother 14:2012\u20132015","journal-title":"Hum Vaccin Immunother"},{"key":"11011_CR37","doi-asserted-by":"publisher","first-page":"112471","DOI":"10.1016\/j.celrep.2023.112471","volume":"42","author":"B Dang","year":"2023","unstructured":"Dang B et al (2023) The glycolysis\/HIF-1\u03b1 axis defines the inflammatory role of IL-4-primed macrophages. Cell Rep 42:112471","journal-title":"Cell Rep"},{"key":"11011_CR38","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nrd4176","volume":"13","author":"R Sabat","year":"2014","unstructured":"Sabat R, Ouyang W, Wolk K (2014) Therapeutic opportunities of the IL-22-IL-22R1 system. Nat Rev Drug Discov 13:21\u201338","journal-title":"Nat Rev Drug Discov"},{"key":"11011_CR39","doi-asserted-by":"publisher","first-page":"766586","DOI":"10.3389\/fimmu.2021.766586","volume":"12","author":"LA Zenewicz","year":"2021","unstructured":"Zenewicz LA (2021) IL-22 Binding Protein (IL-22BP) in the Regulation of IL-22 Biology. Front Immunol 12:766586","journal-title":"Front Immunol"},{"key":"11011_CR40","doi-asserted-by":"publisher","first-page":"4339","DOI":"10.1002\/jcp.30876","volume":"237","author":"Y Chen","year":"2022","unstructured":"Chen Y et al (2022) Kynurenine-3-monooxygenase (KMO): from its biological functions to therapeutic effect in diseases progression. J Cell Physiol 237:4339\u20134355","journal-title":"J Cell Physiol"},{"key":"11011_CR41","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1080\/08830185.2021.1954638","volume":"41","author":"M Ala","year":"2022","unstructured":"Ala M (2022) Tryptophan metabolites modulate inflammatory bowel disease and colorectal cancer by affecting immune system. Int Rev Immunol 41:326\u2013345","journal-title":"Int Rev Immunol"},{"key":"11011_CR42","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1136\/gutjnl-2024-332891","volume":"74","author":"M Hu","year":"2025","unstructured":"Hu M et al (2025) Gut microbial-derived N-acetylmuramic acid alleviates colorectal cancer via the AKT1 pathway. Gut 74:1230\u20131245","journal-title":"Gut"},{"key":"11011_CR43","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1586\/eci.10.34","volume":"6","author":"F van Wijk","year":"2010","unstructured":"van Wijk F, Cheroutre H (2010) Mucosal T cells in gut homeostasis and inflammation. Expert Rev Clin Immunol 6:559\u2013566","journal-title":"Expert Rev Clin Immunol"},{"key":"11011_CR44","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/mi.2013.33","volume":"7","author":"A Eken","year":"2014","unstructured":"Eken A, Singh AK, Treuting PM, Oukka M (2014) IL-23R+ innate lymphoid cells induce colitis via interleukin-22-dependent mechanism. Mucosal Immunol 7:143\u2013154","journal-title":"Mucosal Immunol"},{"key":"11011_CR45","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1084\/jem.20102149","volume":"208","author":"M Kamanaka","year":"2011","unstructured":"Kamanaka M et al (2011) Memory\/effector (CD45RB(lo)) CD4 T cells are controlled directly by IL-10 and cause IL-22-dependent intestinal pathology. J Exp Med 208:1027\u20131040","journal-title":"J Exp Med"},{"key":"11011_CR46","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/gut.52.1.65","volume":"52","author":"S Fujino","year":"2003","unstructured":"Fujino S et al (2003) Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52:65\u201370","journal-title":"Gut"},{"key":"11011_CR47","doi-asserted-by":"publisher","first-page":"G827","DOI":"10.1152\/ajpgi.00513.2005","volume":"290","author":"S Brand","year":"2006","unstructured":"Brand S et al (2006) IL-22 is increased in active Crohn\u2019s disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am J Physiol Gastrointest Liver Physiol 290:G827\u2013838","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"11011_CR48","doi-asserted-by":"publisher","first-page":"592","DOI":"10.2174\/156652412800620066","volume":"12","author":"I Monteleone","year":"2012","unstructured":"Monteleone I, Sarra M, Pallone F, Monteleone G (2012) Th17-related cytokines in inflammatory bowel diseases: friends or foes? Curr Mol Med 12:592\u2013597","journal-title":"Curr Mol Med"},{"key":"11011_CR49","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1084\/jem.20061308","volume":"203","author":"SC Liang","year":"2006","unstructured":"Liang SC et al (2006) Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203:2271\u20132279","journal-title":"J Exp Med"},{"key":"11011_CR50","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/mi.2012.72","volume":"5","author":"CJ Kim","year":"2012","unstructured":"Kim CJ et al (2012) A role for mucosal IL-22 production and Th22 cells in HIV-associated mucosal immunopathogenesis. Mucosal Immunol 5:670\u2013680","journal-title":"Mucosal Immunol"},{"key":"11011_CR51","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.chom.2017.05.009","volume":"21","author":"PY Tsai","year":"2017","unstructured":"Tsai PY et al (2017) IL-22 upregulates epithelial claudin-2 to drive diarrhea and enteric pathogen clearance. Cell Host Microbe 21:671\u2013681.e674","journal-title":"Cell Host Microbe"},{"key":"11011_CR52","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.immuni.2015.09.003","volume":"43","author":"JS Lee","year":"2015","unstructured":"Lee JS et al (2015) Interleukin-23-independent IL-17 production regulates intestinal epithelial permeability. Immunity 43:727\u2013738","journal-title":"Immunity"},{"key":"11011_CR53","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s40168-024-01750-y","volume":"12","author":"G Wang","year":"2024","unstructured":"Wang G et al (2024) Microbiota-derived indoles alleviate intestinal inflammation and modulate microbiome by microbial cross-feeding. Microbiome 12:59","journal-title":"Microbiome"},{"key":"11011_CR54","doi-asserted-by":"publisher","first-page":"5347","DOI":"10.1128\/jb.178.18.5347-5352.1996","volume":"178","author":"D Mengin-Lecreulx","year":"1996","unstructured":"Mengin-Lecreulx D, van Heijenoort J, Park JT (1996) Identification of the mpl gene encoding UDP-N-acetylmuramate: L-alanyl-gamma-D-glutamyl-meso-diaminopimelate ligase in Escherichia coli and its role in recycling of cell wall peptidoglycan. J Bacteriol 178:5347\u20135352","journal-title":"J Bacteriol"},{"key":"11011_CR55","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13099-014-0036-y","volume":"6","author":"LX Lv","year":"2014","unstructured":"Lv LX, Li YD, Hu XJ, Shi HY, Li LJ (2014) Whole-genome sequence assembly of Pediococcus pentosaceus LI05 (CGMCC 7049) from the human gastrointestinal tract and comparative analysis with representative sequences from three food-borne strains. Gut pathogens 6:36","journal-title":"Gut pathogens"},{"key":"11011_CR56","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.cytogfr.2022.07.005","volume":"69","author":"P Jiang","year":"2023","unstructured":"Jiang P et al (2023) The involvement of TH17 cells in the pathogenesis of IBD. Cytokine Growth Factor Rev 69:28\u201342","journal-title":"Cytokine Growth Factor Rev"},{"key":"11011_CR57","doi-asserted-by":"publisher","first-page":"5225","DOI":"10.7150\/thno.43716","volume":"10","author":"YJ Liu","year":"2020","unstructured":"Liu YJ et al (2020) Parthenolide ameliorates colon inflammation through regulating Treg\/Th17 balance in a gut microbiota-dependent manner. Theranostics 10:5225\u20135241","journal-title":"Theranostics"},{"key":"11011_CR58","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00281-019-00733-8","volume":"41","author":"K Yasuda","year":"2019","unstructured":"Yasuda K, Takeuchi Y, Hirota K (2019) The pathogenicity of Th17 cells in autoimmune diseases. Semin Immunopathol 41:283\u2013297","journal-title":"Semin Immunopathol"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-026-11011-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-026-11011-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-026-11011-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:20:00Z","timestamp":1787725200000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-026-11011-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["11011"],"URL":"https:\/\/doi.org\/10.1007\/s12602-026-11011-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7457841\/v1","asserted-by":"object"}]},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}